Competitive: Galderma: The Brand Manager - Biologics will be responsible driving and...
Author - David Miller
Galderma: Clinical Specialist
Competitive: Galderma: Galderma promotes several products to Medical Aesthetic professionals...
FDA Approves Emblaveo (aztreonam and avibactam) for the...
NORTH CHICAGO, Ill., Feb. 7, 2025 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the...
AI tool helps find life-saving medicine for rare disease
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover...
AI accelerates the search for new tuberculosis drug targets
Tuberculosis is a serious global health threat that infected more than 10 million people in 2022...
Omega-3s can slow down aging process
Many people would like to delay or even stop the aging process. Previous clinical studies have...
FDA Approves Onapgo (apomorphine hydrochloride) for the...
ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:...
Cardiovascular disease medications underused globally
Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and...
FDA Approves Genentech’s Susvimo as the First and Only...
South San Francisco, CA — February 4, 2025 — Genentech, a member of the Roche Group...
Gene therapy may be “one shot stop” for rare bone...
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme...